radiopharmaceuticals

radiopharmaceutical radiotherapeutic
Biotech

Novartis secures new radioligand in $900M deal

Novartis licensed a preclinical radioligand from a Chinese biotech the day after Telix announced plans to buy Novartis' isotope supplier ITM.
Darren Incorvaia Sep 22, 2026 1:22pm
MA strategy deal block push come together form

Telix beams into Novartis’ territory with $1.6B ITM acquisition

Sep 21, 2026 5:19am
Alzheimers brain

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify

Aug 17, 2026 7:51am
Graphic image of a red thumbs down against a blue background
Favicon Fierce Pharma

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
MA

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm
Novartis booth at AACR 2026

Novartis drops ph. 2-stage radioligand therapy over poor data

Jul 21, 2026 8:18am